Company news

CLEO Diagnostics Ltd news in 2025

CLEO Diagnostics Ltd's news releases, calls and decks from 2025, newest first.

View company

CLEO Raises $5m to Support U.S. Market Launch

December 17, 2025

Trading Halt

December 16, 2025

Cleo Strengthens Cash Position with $1.7m R&D Tax Refund

November 25, 2025

CLEO Appoints First Key Opinion Leader to Support US Market

November 18, 2025

CLEO Significantly Expands Addressable Market

November 5, 2025

CLEO Successfully Completes Stage 1 MDSAP Audit

October 29, 2025

Cleo Receives Positive FDA Feedback

September 14, 2025

Appendix 4E and 2025 Annual Report

August 26, 2025

COV Commences Health Economic Study-Support US Market Entry

August 17, 2025

CLEO Strengthens FDA Submission - Access to US Biobank

June 25, 2025

Corporate Presentation

June 11, 2025

Cleo Advances with Completion of Alpha Testing

May 12, 2025

CLEO to Fast Track Development of Ovarian Cancer Test

April 27, 2025

CLEO Receives A$845k Research and Development Tax Incentive

April 24, 2025

CLEO Delivers Commercial Development Milestone

March 17, 2025

Price Query Response

February 7, 2025

Decks in 2025